PVA TEPLA AG O.N./ DE0007461006 /
21.06.2024 18:52:46 | Изменение -1.210 | Объем сделки | Бид19:38:30 | Предложение19:38:30 | Рыночная капитализация | Дивидендная доходность | Коэффициент Цена/Доход |
---|---|---|---|---|---|---|---|
15.370EUR | -7.30% | 340 Оборот: 5,225.800 |
-Величина цены спроса: - | -Величина цены предложения: - | 334.51 млнEUR | - | 13.73 |
GlobeNewswire
1:15
Crown Crafts to Announce Fourth Quarter and Full Year Fiscal 2024 Results on June 28, 2024
GlobeNewswire
1:10
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AAN, RPHM on Behalf of Shareholders
GlobeNewswire
0:45
Teladoc Health is Providing Free Virtual Health Care Services to New Mexico Residents Impacted by Wi...
GlobeNewswire
0:38
Toyota Announcement: If You Have Suffered Losses in Toyota Motor Corporation (NYSE: TM), You Are Enc...
GlobeNewswire
0:30
Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-...
GlobeNewswire
0:24
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against UiPath, Inc. (...
GlobeNewswire
0:00
KIP Protocol Partners with Open Campus to Launch Open Campus U, Transforming Education Through Decen...
GlobeNewswire
21.06
Antibody-drug Conjugates Shift the Cancer Treatment Landscape: Novotech Whitepaper Examines Latest C...
GlobeNewswire
21.06
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against NIKE, Inc. (NK...
GlobeNewswire
21.06
NIKE, INC. (NYSE: NIKE) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Act...
GlobeNewswire
21.06
Metasphere Labs Enters a Definitive Agreement with ARCannabis to Develop VR Virtual Store
GlobeNewswire
21.06
In Major Victory For Injured Owners of “Dangerously Defective” Firearm, Federal Jury Awards $2.35 Mi...
GlobeNewswire
21.06
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
21.06
Goodness Growth Holdings Announces Voting Results of Annual General and Special Meeting of Sharehold...
GlobeNewswire
21.06
argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropat...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница